190 related articles for article (PubMed ID: 12354543)
1. Pathological and immunohistochemical study of the liver and hepatic lymph nodes of sheep chronically reinfected with Fasciola hepatica, with or without triclabendazole treatment.
Pérez J; Ortega J; Moreno T; Morrondo P; López-Sández C; Martínez-Moreno A
J Comp Pathol; 2002 Jul; 127(1):30-6. PubMed ID: 12354543
[TBL] [Abstract][Full Text] [Related]
2. Phenotype of hepatic infiltrates and hepatic lymph nodes of lambs primarily and challenge infected with Fasciola hepatica, with and without triclabendazole treatment.
Pérez J; Ortega J; Bravo A; Díez-Baños P; Morrondo P; Moreno T; Martínez-Moreno A
Vet Res; 2005; 36(1):1-12. PubMed ID: 15610719
[TBL] [Abstract][Full Text] [Related]
3. Resistance of Fasciola hepatica against triclabendazole in cattle and sheep in The netherlands.
Moll L; Gaasenbeek CP; Vellema P; Borgsteede FH
Vet Parasitol; 2000 Jul; 91(1-2):153-8. PubMed ID: 10889368
[TBL] [Abstract][Full Text] [Related]
4. Fasciola hepatica: histological changes in the reproductive structures of triclabendazole (TCBZ)-sensitive and TCBZ-resistant flukes after treatment in vivo with TCBZ and the related benzimidazole derivative, Compound Alpha.
Hanna RE; Edgar HW; McConnell S; Toner E; McConville M; Brennan GP; Devine C; Flanagan A; Halferty L; Meaney M; Shaw L; Moffett D; McCoy M; Fairweather I
Vet Parasitol; 2010 Mar; 168(3-4):240-54. PubMed ID: 20053501
[TBL] [Abstract][Full Text] [Related]
5. Fasciola hepatica: a comparative survey of adult fluke resistance to triclabendazole, nitroxynil and closantel on selected upland and lowland sheep farms in Northern Ireland using faecal egg counting, coproantigen ELISA testing and fluke histology.
Hanna RE; McMahon C; Ellison S; Edgar HW; Kajugu PE; Gordon A; Irwin D; Barley JP; Malone FE; Brennan GP; Fairweather I
Vet Parasitol; 2015 Jan; 207(1-2):34-43. PubMed ID: 25529143
[TBL] [Abstract][Full Text] [Related]
6. Comparative efficacy of closantel and triclabendazole against Fasciola hepatica in experimentally infected sheep.
Maes L; Vanparijs O; Lauwers H; Deckers W
Vet Rec; 1990 Nov; 127(18):450-2. PubMed ID: 2275080
[TBL] [Abstract][Full Text] [Related]
7. Time-course and accumulation of triclabendazole and its metabolites in bile, liver tissues and flukes collected from treated sheep.
Moreno L; Ceballos L; Fairweather I; Lanusse C; Alvarez L
Exp Parasitol; 2014 Jan; 136():14-9. PubMed ID: 24211244
[TBL] [Abstract][Full Text] [Related]
8. Extension of the prepatent period of Fasciola hepatica in infected animals following treatment with triclabendazole.
Büscher G; Bowen FL; Strong MB; Allison JR; Richards RJ
Vet Rec; 1987 May; 120(19):460-1. PubMed ID: 3603988
[No Abstract] [Full Text] [Related]
9. Clonal amplification of Fasciola hepatica in Galba truncatula: within and between isolate variation of triclabendazole-susceptible and -resistant clones.
Hodgkinson JE; Cwiklinski K; Beesley N; Hartley C; Allen K; Williams DJL
Parasit Vectors; 2018 Jun; 11(1):363. PubMed ID: 29941045
[TBL] [Abstract][Full Text] [Related]
10. Resistance of Fasciola hepatica against Triclabendazole in cattle in Cajamarca (Peru): a clinical trial and an in vivo efficacy test in sheep.
Ortiz P; Scarcella S; Cerna C; Rosales C; Cabrera M; Guzmán M; Lamenza P; Solana H
Vet Parasitol; 2013 Jul; 195(1-2):118-21. PubMed ID: 23352107
[TBL] [Abstract][Full Text] [Related]
11. A study of a restricted programme of strategic dosing against Fasciola hepatica with triclabendazole.
Fawcett AR
Vet Rec; 1990 Nov; 127(20):492-3. PubMed ID: 2275087
[TBL] [Abstract][Full Text] [Related]
12. Resistance of Fasciola hepatica to triclabendazole.
Overend DJ; Bowen FL
Aust Vet J; 1995 Jul; 72(7):275-6. PubMed ID: 8534235
[No Abstract] [Full Text] [Related]
13. Distribution of Foxp3
Escamilla A; Zafra R; Pérez J; McNeilly TN; Pacheco IL; Buffoni L; Martínez-Moreno FJ; Molina-Hernández V; Martínez-Moreno A
Vet Parasitol; 2016 Oct; 230():14-19. PubMed ID: 27884436
[TBL] [Abstract][Full Text] [Related]
14. The field evaluation of albendazole and triclabendazole efficacy against Fasciola hepatica by coproantigen ELISA in naturally infected sheep.
Novobilský A; Averpil HB; Höglund J
Vet Parasitol; 2012 Nov; 190(1-2):272-6. PubMed ID: 22818198
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of nitroxynil against Fasciola hepatica resistant to triclabendazole in a naturally infected sheep flock.
Martínez-Valladares M; del Rosario Famularo M; Fernández-Pato N; Castañón-Ordóñez L; Cordero-Pérez C; Rojo-Vázquez FA
Parasitol Res; 2010 Oct; 107(5):1205-11. PubMed ID: 20680341
[TBL] [Abstract][Full Text] [Related]
16. Unchanged triclabendazole kinetics after co-administration with ivermectin and methimazole: failure of its therapeutic activity against triclabendazole-resistant liver flukes.
Ceballos L; Moreno L; Alvarez L; Shaw L; Fairweather I; Lanusse C
BMC Vet Res; 2010 Feb; 6():8. PubMed ID: 20128898
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of triclabendazole against Fasciola hepatica in sheep and goats.
Wolff K; Eckert J; Schneiter G; Lutz H
Vet Parasitol; 1983 Sep; 13(2):145-50. PubMed ID: 6685399
[TBL] [Abstract][Full Text] [Related]
18. An evaluation of the efficacy of compound alpha and triclabendazole against two isolates of Fasciola hepatica.
McConville M; Brennan GP; Flanagan A; Edgar HW; Hanna RE; McCoy M; Gordon AW; Castillo R; Hernández-Campos A; Fairweather I
Vet Parasitol; 2009 May; 162(1-2):75-88. PubMed ID: 19282108
[TBL] [Abstract][Full Text] [Related]
19. Comparative kinetics of serological and coproantigen ELISA and faecal egg count in cattle experimentally infected with Fasciola hepatica and following treatment with triclabendazole.
Brockwell YM; Spithill TW; Anderson GR; Grillo V; Sangster NC
Vet Parasitol; 2013 Sep; 196(3-4):417-26. PubMed ID: 23643623
[TBL] [Abstract][Full Text] [Related]
20. Anthelmintic efficacy of triclabendazole against Fasciola hepatica in sheep.
Turner K; Armour J; Richards RJ
Vet Rec; 1984 Jan; 114(2):41-2. PubMed ID: 6719804
[No Abstract] [Full Text] [Related]
[Next] [New Search]
